STASSI, Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 15.432
EU - Europa 6.096
AS - Asia 4.853
SA - Sud America 1.020
AF - Africa 149
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 10
Totale 27.574
Nazione #
US - Stati Uniti d'America 15.277
IT - Italia 1.942
SG - Singapore 1.769
CN - Cina 1.535
BR - Brasile 849
FI - Finlandia 668
UA - Ucraina 666
DE - Germania 632
HK - Hong Kong 538
RU - Federazione Russa 525
GB - Regno Unito 389
IE - Irlanda 330
VN - Vietnam 322
PL - Polonia 237
SE - Svezia 174
FR - Francia 128
KR - Corea 112
IN - India 109
NL - Olanda 108
CA - Canada 79
BE - Belgio 72
TR - Turchia 72
CI - Costa d'Avorio 62
JP - Giappone 61
RO - Romania 60
AR - Argentina 58
AT - Austria 53
BD - Bangladesh 46
MX - Messico 43
IQ - Iraq 32
UZ - Uzbekistan 32
EC - Ecuador 31
IR - Iran 30
ID - Indonesia 25
SA - Arabia Saudita 25
ZA - Sudafrica 25
ES - Italia 23
VE - Venezuela 23
MY - Malesia 22
CZ - Repubblica Ceca 21
PK - Pakistan 17
CH - Svizzera 16
CL - Cile 15
KE - Kenya 15
CO - Colombia 14
GR - Grecia 13
NP - Nepal 13
PY - Paraguay 13
KZ - Kazakistan 12
MA - Marocco 11
AU - Australia 10
EG - Egitto 10
UY - Uruguay 9
AZ - Azerbaigian 8
BG - Bulgaria 8
JO - Giordania 8
CR - Costa Rica 7
EU - Europa 7
KG - Kirghizistan 7
QA - Qatar 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
ET - Etiopia 6
BH - Bahrain 5
HN - Honduras 5
LB - Libano 5
PE - Perù 5
RS - Serbia 5
JM - Giamaica 4
LU - Lussemburgo 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
OM - Oman 4
PA - Panama 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
IL - Israele 3
LT - Lituania 3
PH - Filippine 3
PT - Portogallo 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
TW - Taiwan 3
A1 - Anonimo 2
AL - Albania 2
BY - Bielorussia 2
EE - Estonia 2
GE - Georgia 2
GT - Guatemala 2
KW - Kuwait 2
LV - Lettonia 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
Totale 27.557
Città #
Fairfield 2.131
Ashburn 1.858
Chandler 1.150
Woodbridge 1.106
Singapore 1.047
Houston 882
Wilmington 789
Cambridge 787
Seattle 772
Ann Arbor 764
Palermo 548
Hong Kong 521
Jacksonville 365
Dublin 327
Medford 261
Beijing 251
New York 224
Moscow 210
The Dalles 208
Des Moines 200
Hefei 196
Zgierz 195
Los Angeles 194
Nanjing 180
Altamura 175
Princeton 173
Dallas 166
Boardman 158
Lawrence 141
San Diego 133
Ho Chi Minh City 114
Dearborn 109
Tulsa 99
Rome 95
Santa Clara 94
Buffalo 92
London 89
São Paulo 85
Milan 83
Ludwigshafen am Rhein 76
Hanoi 68
Chicago 63
Brussels 62
Abidjan 61
Council Bluffs 59
Seoul 57
Munich 54
Nuremberg 50
Phoenix 50
Nanchang 49
Tokyo 48
Berlin 47
Changsha 47
Shenyang 44
Seongnam 43
Columbus 39
Falls Church 39
Helsinki 39
Tianjin 38
Bremen 37
Hebei 37
Kumar 36
Izmir 35
Stockholm 34
Rio de Janeiro 33
Frankfurt am Main 32
Jinan 31
Warsaw 30
Guangzhou 29
San Paolo di Civitate 29
Brooklyn 27
Tashkent 27
Jiaxing 26
Orem 26
Redwood City 26
Saint Petersburg 26
Shanghai 26
Montreal 25
Lappeenranta 24
Denver 23
Poplar 23
Roden 23
Toronto 22
Vienna 22
Amsterdam 21
Ningbo 21
Venice 21
Chennai 20
Da Nang 20
Belo Horizonte 17
Hangzhou 17
Turku 17
Boston 16
Olomouc 16
San Giovanni in Persiceto 16
Zhengzhou 16
Catania 15
Haiphong 15
Verona 15
Curitiba 14
Totale 18.991
Nome #
Combined platelet-rich plasma and lipofilling treatment provides great improvement in facial skin-induced lesion regeneration for scleroderma patients 370
High Levels of Exogenous C2-Ceramide Promote Morphological and Biochemical Evidences of Necrotic Features in Thyroid Follicular Cells 341
CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis 302
IL4 primes the dynamics of breast cancer progression via DUSP4 inhibition 295
Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance 279
Squamous cell tumors recruit γδ T cells producing either IL17 or IFNγ depending on the tumor stage 270
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells 261
Activated thyroid hormone promotes differentiation and chemotherapeutic sensitization of colorectal cancer stem cells by regulating Wnt and BMP4 signaling 258
DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells 258
Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas 255
Metabolic Escape Routes of Cancer Stem Cells and Therapeutic Opportunities 247
Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells 243
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant 243
Colon Cancer Stem Cells: Bench-to-Bedside—New Therapeutical Approaches in Clinical Oncology for Disease Breakdown 239
Cancer stem cell definitions and terminology: the devil is in the details 239
Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4 229
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells. 228
Distinctive features of tumor-infiltrating gd T lymphocytes in human colorectal cancer 228
Colorectal cancer defeating? Challenge accepted! 224
A BMP7 variant inhibits tumor angiogenesis in vitro and in vivo through direct modulation of endothelial cell biology 222
By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy 221
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4 219
Tumor and its microenvironment: a synergistic interplay. 218
Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer 216
Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models 216
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin 213
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 212
MUC1 Oncoprotein Promotes Refractoriness to Chemotherapy in Thyroid Cancer Cells 211
Aurora-a is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells. 209
Suppressor of cytokine signaling 3 sensitizes anaplastic thyroid cancer to standard chemotherapy 205
Normal vs cancer thyroid stem cells: the road to transformation 204
Nobiletin and Xanthohumol Sensitize Colorectal Cancer Stem Cells to Standard Chemotherapy 200
PED Mediates AKT-Dependent Chemoresistance in Human Breast Cancer Cells 198
Survivin is regulated by interleukin-4 in colon cancer stem cells 197
Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility Study. 196
Immunotherapy targeting colon cancer stem cells 195
Innovative Therapeutic Strategies Targeting Colorectal Cancer Stem Cells 195
Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment 194
Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes 193
ΔNp63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis 193
CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells 193
Erythropoietin activates cell survival pathways in breast cancer stem-like cells to protect them from chemotherapy 192
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 192
Colorectal Cancer Stem Cells: From the Crypt to the Clinic 190
Carboxyamidotriazole inhibits cell growth of imatinib-resistant chronic myeloid leukaemia cells including T315I Bcr-Abl mutant by a redox-mediated mechanism. 190
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma 189
Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. 189
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells 185
Meeting the Challenge of Targeting Cancer Stem Cells 185
IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins 184
Isolation and culture of colon cancer stem cells. 182
Therapeutic implications of Cancer Initiating Cells. 182
Induction of annexin-1 during TRAIL-induced apoptosis in thyroid carcinoma cells 181
Cancer cell targeting by CAR-T cells: A matter of stemness 180
CANCER STEM CELLS CONTRIBUTE TO THE AGGRESSIVE BEHAVIOUR OF HUMAN EPITHELIAL COLON CANCER. 180
γδ T cells as a potential tool in colon cancer immunotherapy 180
Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. 179
Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs 179
Lipid droplets: A New Player in Colorectal Cancer Stem Cells Unveiled by Spectroscopic Imaging 178
Heart infarct in NOD-SCID mice: therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34+KDR+ cells 174
Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. 174
IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins 174
A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype 171
Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme 170
Estrogens and stem cells in thyroid cancer 169
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells 165
Mechanisms underlying lineage commitment and plasticity of human γδ T cells. 165
Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs 164
Microenvironment in neuroblastoma: Isolation and characterization of tumor-derived mesenchymal stromal cells 164
Identification and phenotypic characterization of a subpopulation of T84 human colon cancer cells, after selection on activated endothelial cells 162
IL-4-mediated drug resistance in colon cancer stem cells 162
Autocrine production of IL-4 confers resistance to chemotherapy and CD-95 induced cell death in cancer cells. 160
Tumorigenic and metastatic activity of human thyroid cancer stem cells 159
Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules 159
Involvement of caspase-3 and GD3 ganglioside in ceramide-induced apoptosis in Farber disease 159
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery 158
Colon cancer stem cells: promise of targeted therapy. 157
Erratum: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy 157
Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy 156
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells 155
CD133 as a target for colon cancer. 154
IL-21 regulates the differentiation of a human γδ T cell subset equipped with B cell helper activity. 153
Apoptosis induced by a HIPK2 full-length-specific siRNA is due to off-target effects rather than prevalence of HIPK2-Δe8 isoform. 153
ROS and Lipid Droplet accumulation induced by high glucose exposure in healthy colon and Colorectal Cancer Stem Cells 153
The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. 152
Dual targeting of HER3 and MEK may overcome HER3-dependent drug-resistance of colon cancers 152
ANTIBODY SPECIFIC FOR HUMAN IL-4 FOR THE TREAMENT OF CANCER 151
In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. 151
Cancer-Initiating Cells from Colorectal cancer Patients Escape from T Cell-Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4 150
Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells 149
V{gamma}9V{delta}2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells. 148
Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer 147
Inhibition of DNA Methylation Sensitizes Glioblastoma for Tumor Necrosis Factor–Related Apoptosis-Inducing igand–Mediated Destruction. 145
Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer 145
Role of interleukin-4 on colon cancer stem cell survival 144
Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51 143
Crucial role of interleukin-4 in the survival of colon cancer stem cells 141
Role of Type I and II interferons in colorectal cancer and melanoma 140
Human fetal aorta contains vascular progenitor cells capable of inducing vasculogenesis, angiogenesis, and myogenesis in vitro and in a murine model of peripheral ischemia. 140
ROLE OF IL-4 AND IL-10 CYTOKYNES IN THE PATHOGENIC MECHANISM OF THYROID CANCER. 139
Totale 19.230
Categoria #
all - tutte 108.166
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.166


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.875 0 0 0 0 0 108 260 264 288 402 290 263
2021/20222.621 145 503 100 82 151 97 143 140 301 319 187 453
2022/20233.272 310 584 59 404 343 564 184 225 370 39 129 61
2023/20241.506 88 211 93 91 116 301 161 98 17 48 18 264
2024/20254.035 110 257 196 339 141 140 300 316 283 525 526 902
2025/20265.451 1.071 376 851 1.080 1.295 778 0 0 0 0 0 0
Totale 28.623